Cinven eyes US medtech firms looking to Europe

Cinven currently has just two healthcare investments: Labco, and US pharma contract research group Medpace, which it acquired for $915 million in 2014.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this